(Q53089445)

11 May 2018

title

Serum microRNA expression profiling predict response to R-CHOP treatment in diffuse large B cell lymphoma patients. (English)

1 reference

11 May 2018

0 references

Guoqi Song

1

1 reference

11 May 2018

Ling Gu

2

1 reference

11 May 2018

Junhong Li

3

1 reference

11 May 2018

Zhipeng Tang

4

1 reference

11 May 2018

Hong Liu

5

1 reference

11 May 2018

Baoan Chen

6

1 reference

11 May 2018

Xuemei Sun

7

1 reference

11 May 2018

Bangsun He

8

1 reference

11 May 2018

Yuqin Pan

9

1 reference

11 May 2018

Shukui Wang

10

1 reference

11 May 2018

William C Cho

11

1 reference

11 May 2018

publication date

25 May 2014

1 reference

11 May 2018

published in

Annals of Hematology

1 reference

11 May 2018

volume

93

1 reference

11 May 2018

issue

10

1 reference

11 May 2018

page(s)

1735-1743

1 reference

11 May 2018

Diffuse large cell lymphoma

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Diffuse large B-cell lymphoma: a heterogeneous group of non-Hodgkin lymphomas comprising several distinct clinicopathological entities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Prognostic biomarkers in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

MicroRNA expression, survival, and response to interferon in liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

A microRNA component of the p53 tumour suppressor network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Statin-independent prognosis of patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Variability in immunophenotype in diffuse large B-cell lymphoma and its clinical relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Combinatorial microRNA target predictions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Computational identification of microRNA targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Prediction of mammalian microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Circulating microRNAs as novel minimally invasive biomarkers for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Circulating microRNAs in plasma of patients with gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

Detection and Characterization of Placental MicroRNAs in Maternal Plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2111-3

10.1007/S00277-014-2111-3

21 January 2018

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018